Hbm Healthcare Investments (cayman) Ltd. - Net Worth and Insider Trading

Hbm Healthcare Investments (cayman) Ltd. Net Worth

The estimated net worth of Hbm Healthcare Investments (cayman) Ltd. is at least $321 Million dollars as of 2024-11-13. Hbm Healthcare Investments (cayman) Ltd. is the 10% Owner of IVERIC bio Inc and owns about 3,139,902 shares of IVERIC bio Inc (ISEE) stock worth over $125 Million. Hbm Healthcare Investments (cayman) Ltd. is the 10% Owner of PTC Therapeutics Inc and owns about 2,441,504 shares of PTC Therapeutics Inc (PTCT) stock worth over $109 Million. Hbm Healthcare Investments (cayman) Ltd. is also the 10% Owner of Mineralys Therapeutics Inc and owns about 3,218,106 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $43 Million. Besides these, Hbm Healthcare Investments (cayman) Ltd. also holds Pacira BioSciences Inc (PCRX) , Paratek Pharmaceuticals Inc (PRTK) , IO Biotech Inc (IOBT) , Nabriva Therapeutics PLC (NBRVF) . Details can be seen in Hbm Healthcare Investments (cayman) Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hbm Healthcare Investments (cayman) Ltd. has not made any transactions after 2023-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Hbm Healthcare Investments (cayman) Ltd.

To

Hbm Healthcare Investments (cayman) Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hbm Healthcare Investments (cayman) Ltd. owns 9 companies in total, including Nabriva Therapeutics PLC (NBRVF) , Paratek Pharmaceuticals Inc (PRTK) , and Apollo Endosurgery Inc (APEN) among others .

Click here to see the complete history of Hbm Healthcare Investments (cayman) Ltd.’s form 4 insider trades.

Insider Ownership Summary of Hbm Healthcare Investments (cayman) Ltd.

Ticker Comapny Transaction Date Type of Owner
NBRVF Nabriva Therapeutics PLC 2017-09-14 10 percent owner
PRTK Paratek Pharmaceuticals Inc 2015-05-29 10 percent owner
APEN Apollo Endosurgery Inc 2014-09-26 10 percent owner
LIMIT LIMIT 2014-05-13 10 percent owner
LIMIT LIMIT 2013-12-17 10 percent owner
LIMIT LIMIT 2013-03-25 10 percent owner
LIMIT LIMIT 2021-04-29 10 percent owner
LIMIT LIMIT 2021-11-09 10 percent owner
LIMIT LIMIT 2023-02-14 10 percent owner

Hbm Healthcare Investments (cayman) Ltd. Latest Holdings Summary

Hbm Healthcare Investments (cayman) Ltd. currently owns a total of 7 stocks. Among these stocks, Hbm Healthcare Investments (cayman) Ltd. owns 3,139,902 shares of IVERIC bio Inc (ISEE) as of May 13, 2014, with a value of $125 Million and a weighting of 39.03%. Hbm Healthcare Investments (cayman) Ltd. owns 2,441,504 shares of PTC Therapeutics Inc (PTCT) as of December 17, 2013, with a value of $109 Million and a weighting of 33.9%. Hbm Healthcare Investments (cayman) Ltd. also owns 3,218,106 shares of Mineralys Therapeutics Inc (MLYS) as of February 14, 2023, with a value of $43 Million and a weighting of 13.4%. The other 4 stocks Pacira BioSciences Inc (PCRX) , Paratek Pharmaceuticals Inc (PRTK) , IO Biotech Inc (IOBT) , Nabriva Therapeutics PLC (NBRVF) have a combined weighting of 13.67% among all his current holdings.

Latest Holdings of Hbm Healthcare Investments (cayman) Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ISEE IVERIC bio Inc 2014-05-13 3,139,902 39.95 125,439,085
PTCT PTC Therapeutics Inc 2013-12-17 2,441,504 44.62 108,939,908
MLYS Mineralys Therapeutics Inc 2023-02-14 3,218,106 13.38 43,058,258
PCRX Pacira BioSciences Inc 2013-03-25 2,233,993 16.81 37,553,422
PRTK Paratek Pharmaceuticals Inc 2015-05-29 1,747,680 2.23 3,897,326
IOBT IO Biotech Inc 2021-11-09 2,690,545 0.93 2,495,211
NBRVF Nabriva Therapeutics PLC 2017-09-14 9,337 0.00 1

Holding Weightings of Hbm Healthcare Investments (cayman) Ltd.


Hbm Healthcare Investments (cayman) Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Hbm Healthcare Investments (cayman) Ltd. has made a total of 0 transactions in IVERIC bio Inc (ISEE) over the past 5 years. The most-recent trade in IVERIC bio Inc is the sale of 500,000 shares on May 13, 2014, which brought Hbm Healthcare Investments (cayman) Ltd. around $15 Million.

According to the SEC Form 4 filings, Hbm Healthcare Investments (cayman) Ltd. has made a total of 0 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years. The most-recent trade in PTC Therapeutics Inc is the sale of 66,667 shares on December 17, 2013, which brought Hbm Healthcare Investments (cayman) Ltd. around $1 Million.

According to the SEC Form 4 filings, Hbm Healthcare Investments (cayman) Ltd. has made a total of 1 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mineralys Therapeutics Inc is the acquisition of 312,500 shares on February 14, 2023, which cost Hbm Healthcare Investments (cayman) Ltd. around $5 Million.

More details on Hbm Healthcare Investments (cayman) Ltd.'s insider transactions can be found in the Insider Trading History of Hbm Healthcare Investments (cayman) Ltd. table.

Insider Trading History of Hbm Healthcare Investments (cayman) Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hbm Healthcare Investments (cayman) Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Hbm Healthcare Investments (cayman) Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hbm Healthcare Investments (cayman) Ltd. is 14.31%. GuruFocus also compares Hbm Healthcare Investments (cayman) Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Hbm Healthcare Investments (cayman) Ltd. within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hbm Healthcare Investments (cayman) Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hbm Healthcare Investments (cayman) Ltd.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.63 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.25 LIMIT LIMIT LIMIT LIMIT LIMIT

Hbm Healthcare Investments (cayman) Ltd. Ownership Network

Ownership Network List of Hbm Healthcare Investments (cayman) Ltd.

No Data

Ownership Network Relation of Hbm Healthcare Investments (cayman) Ltd.

Insider Network Chart

Hbm Healthcare Investments (cayman) Ltd. Owned Company Details

What does Nabriva Therapeutics PLC do?

Who are the key executives at Nabriva Therapeutics PLC?

Hbm Healthcare Investments (cayman) Ltd. is the 10 percent owner of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .

Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nabriva Therapeutics PLC Insider Transactions

No Available Data

Hbm Healthcare Investments (cayman) Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Hbm Healthcare Investments (cayman) Ltd.. You might contact Hbm Healthcare Investments (cayman) Ltd. via mailing address: Governors Square, 23 Lime Tree Bay Ave.,, Po Box 30852, Grand Cayman E9 Ky1-1204.